Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.58 |
| ▸ | NAAA | Q02083 | 1/20 | 0.55 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.52 |
| ▸ | FAAH | O00519 | 8/20 | 0.50 |
| ▸ | CES1 | P23141 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.47 |
| ▸ | RAD52 | P43351 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5470496 | 1.00 | CES2 (0.58) | CES2NAAAEPHX1FAAHCES1 | |
| SCHEMBL28781368 | 1.00 | CES2 (0.58) | CES2NAAAEPHX1FAAHCES1 | |
| SCHEMBL28472787 | 1.00 | CES2 (0.58) | CES2NAAAEPHX1FAAHCES1 | |
| SCHEMBL4361492 | 1.00 | CES2 (0.58) | CES2NAAAEPHX1FAAHCES1 | |
| SCHEMBL1123659 | 1.00 | CES2 (0.58) | CES2NAAAEPHX1FAAHCES1 | |
| SCHEMBL4080844 | 1.00 | CES2 (0.58) | CES2NAAAEPHX1FAAHCES1 | |
| SCHEMBL30475134 | 1.00 | CES2 (0.58) | CES2NAAAEPHX1FAAHCES1 | |
| SCHEMBL2691990 | 1.00 | CES2 (0.58) | CES2NAAAEPHX1FAAHCES1 | |
| SCHEMBL4255348 | 1.00 | CES2 (0.58) | CES2NAAAEPHX1FAAHCES1 | |
| SCHEMBL2691404 | 1.00 | CES2 (0.58) | CES2NAAAEPHX1FAAHCES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240084343-A1 | METHODS OF USING NATURAL AND ENGINEERED ORGANISMS TO PRODUCE SMALL MOLECULES FOR INDUSTRIAL APPLICATION | KIVERDI INC (US) | 2024-03-14 | — | — | US | disclosed |
| US-20210115481-A1 | Methods of Using Natural and Engineered Organisms to Produce Small Molecules for Industrial Application | KIVERDI INC (US) | 2021-04-22 | — | — | US | disclosed |
| US-20170159087-A1 | Methods of Using Natural and Engineered Organisms to Produce Small Molecules for Industrial Application | KIVERDI, INC. (US) | 2017-06-08 | — | — | US | disclosed |
| US-9556462-B2 | Methods of using natural and engineered organisms to produce small molecules for industrial application | KIVERDI, INC. (US) | 2017-01-31 | — | — | US | disclosed |
| EP-2971023-A2 | METHODS OF USING NATURAL AND ENGINEERED ORGANISMS TO PRODUCE SMALL MOLECULES FOR INDUSTRIAL APPLICATION | Kiverdi, Inc. (US) | 2016-01-20 | — | — | EP | disclosed |
| WO-2014145194-A2 | METHODS OF USING NATURAL AND ENGINEERED ORGANISMS TO PRODUCE SMALL MOLECULES FOR INDUSTRIAL APPLICATION | KIVERDI, INC. (US) | 2014-09-18 | — | — | WO | disclosed |
| US-20140273112-A1 | METHODS OF USING NATURAL AND ENGINEERED ORGANISMS TO PRODUCE SMALL MOLECULES FOR INDUSTRIAL APPLICATION | KIVERDI, INC. (US) | 2014-09-18 | — | — | US | disclosed |
| EP-1648873-A4 | NEUROPROTECTIVE MACROCYLIC COMPOUNDS AND METHODS FOR THEIR USE | NEUREN PHARMACEUTICALS LTD (NZ) | 2008-06-25 | — | — | EP | disclosed |
| EP-1648873-A2 | NEUROPROTECTIVE MACROCYLIC COMPOUNDS AND METHODS FOR THEIR USE | Neuronz Limited (NZ) | 2006-04-26 | — | — | EP | disclosed |
| WO-2004084809-A2 | NEUROPROTECTIVE MACROCYLIC COMPOUNDS AND METHODS FOR THEIR USE | NEUREN PHARMACEUTICALS LTD. (NZ) | 2004-10-07 | — | — | WO | disclosed |